​

All specific metrics — ARR targets, contract values, user base percentages, and competitive pricing — are indicative placeholders. Replace with verified internal data before distribution.

Hume Band 2.0 – Premium Wearable at a Great Price Limited-Time Deal​

​

Launch Window

Q3 2026 General Availability

Coverage

8 Cards · Features · Metrics · Roadmap · Competitive Position

Hardware

Full redesign · titanium · 14-day battery

Sensors

6 new biometric sensors including ECG + glucose

AI Engine

On-device ML trained on 2M+ user data points

Market

500K users · $85M ARR targeted by 2027

What's New in 2.0: A Generational Leap

PURCHASE NOW This Special Sale Offer Today! ​

Hume Band 2.0 is not an incremental refresh — it is a ground-up redesign across hardware, sensor architecture, and AI, closing the gap between consumer wearables and clinical-grade monitoring. Every dimension of the product has been materially upgraded relative to 1.0.

Complete Hardware Redesign

Slimmer profile with medical-grade titanium casing. Battery life doubles to 14 days (up from 7 days in 1.0). Always-on AMOLED display with adaptive brightness delivers real-time health score at a glance. Water resistance rated at 5ATM — swim-proof for open water and pool tracking.

Expanded Sensor Suite

6 new biometric sensors added in 2.0: continuous blood glucose estimation, skin temperature, SpO2, HRV, ECG, and galvanic skin response. Each sensor is purpose-selected for longevity and metabolic health — not marketing coverage.

AI Longevity Engine v2

On-device ML model trained on 2M+ user data points . Delivers personalized biological age estimates updated daily. Runs entirely on-device for privacy — no raw biometric data leaves the hardware without consent.

Clinical-Grade Accuracy

Heart rate accuracy improved to ±1 BPM . Sleep staging accuracy reaches 94% versus polysomnography gold standard — a benchmark no consumer wearable has previously claimed with published validation data.

Sensor Architecture

What We Measure and Why

Hume Band 2.0 Sale – Limited Stock! Exclusive Deal Available Now​

The 2.0 sensor suite is architected around a single thesis: longevity is a composite of metabolic, cardiovascular, neurological, and recovery signals. Each sensor is mapped to a clinically validated biomarker rather than a consumer-friendly marketing claim.

Continuous ECG

Detects atrial fibrillation and irregular rhythms via FDA-cleared algorithm . On-demand 30-second readings; passive background monitoring during sleep and rest. The only sensor in 2.0 with an active regulatory clearance pathway.

Blood Glucose Estimation

Non-invasive optical sensor with trend-based alerts for pre-diabetic risk patterns. Validated against CGM devices. Does not replace CGM — provides directional trend data actionable for lifestyle intervention.

HRV (Heart Rate Variability)

Primary longevity biomarker in the Hume model. Tracks autonomic nervous system balance; correlates with recovery readiness, chronic stress load, and biological age trajectory. Measured nightly during deep sleep for highest signal quality.

Galvanic Skin Response + Motion

#HumeBand #HumeBand2 #HumeHealth #Hume #WearableTech #HealthTech #FitnessTracker #SmartWearable #HealthTracking #FitnessTech #Recovery #SleepTracking #WellnessTech #Biometrics #SmartHealth